Feno closes $6 million seed funding round
Share Ventures, a venture firm with both a venture studio and a fund committed to transforming human performance through frontier technology, is proudly announcing that Feno, a groundbreaking company dedicated to revolutionizing oral health, has closed its $6 million seed funding round. Co-founded by Dr. Kenny Brown and Share Ventures, Feno embodies the synergy of expert knowledge and innovative vision that defines our studio’s unique approach.
Dr. Kenny Brown joined Share Ventures as an Entrepreneur in Residence (EIR) to explore advancements in oral health. “At Share Ventures, we are dedicated to identifying transformative ideas that reimagine entire industries and pair them with unparalleled expertise. Dr. Kenny Brown’s expertise was instrumental in designing a solution,” said Hamet Watt, CEO and Founder of Share Ventures.
With Feno, we saw a compelling opportunity to reimagine the oral health sector and address root causes. Nearly half of adults over 30 have gum disease, which is linked to heart disease, diabetes, and other health conditions.
Hamet Watt, CEO and Founder, Share Ventures
Feno introduces a smart toothbrush that integrates advanced technology to enhance oral hygiene practices. The product is designed to provide users with real-time feedback and personalized insights, ensuring optimal dental care and long-term health benefits.
“The evidence is staggering,” says Dr. Brown. “How you take care of your oral health is indisputably linked to your overall health in ways that have real-life consequences. The mouth-body connection is only part of this high-stakes equation. The tools we clean our teeth with at home have remained in the Middle Ages. Today’s toothbrushes bear a striking resemblance to those used in the 1500s, and technology that could make brushing more effective and even offer insights is largely absent. Our team at Feno sees an exciting opportunity and a stark need to usher in a new era of at-home oral care that incorporates all of the research and technology like artificial intelligence we have at our fingertips.”
The company’s flagship device, the Feno Smartbrush™, marks the first step in transforming oral health. It was meticulously engineered to harness cutting-edge science, design, and technology to deliver a comprehensive clean in a 20-second full-mouth brushing cycle. The Smarthbrush is the first full-mouth brush in the world to offer oral health insights through the in-device high-definition oral scanner. Powered by artificial intelligence and our expert dental team, the scanning feature is designed to not only help detect potential oral health issues early but also provide personalized oral health insights and recommendations through the Feno app.
Share Ventures’ unique model for building businesses focuses on identifying innovative ideas and providing the necessary expertise and leadership to bring them to fruition. The venture studio has successfully ideated and built several innovative startups by leveraging its unique infrastructure, deep bench of multidisciplinary talent, and backing from prominent investors.
For more information about Feno and to stay updated on its developments, visit Feno.co.
About Feno
Feno is a health-tech company championing the movement to advance oral care as the gateway to health. It blends the precision of advanced dental technology with the simplicity of everyday use to make oral health effortless. The Feno Smartbrush™ is the world’s first full-mouth smartbrush that can brush all teeth in just 20 seconds and provides detailed health insights via the device’s built-in high-definition scanner and connected app. Personalized oral health recommendations, on-demand teledentistry, and detailed health analytics offer a level of depth, understanding, and care never seen in at-home oral care.
About Share Ventures
Share Ventures is a venture studio dedicated to transforming human performance through frontier technology. By leveraging a venture studio model, we build multiple companies simultaneously, focusing on sectors such as health, longevity, and human performance. Our cap table includes investors from Google and Amazon, and we collaborate with leading institutions like Stanford, Wharton, and the University of Michigan.